HARUROPI — 2368974

Toolbar

Details

Application number

2368974

Registration number

TMA1372622

Type(s)

Standard Characters

Category

Trademark

CIPO Status

REGISTERED

TM5 status

LIVE/REGISTRATION/Issued and Active
The trademark application has been registered with the Office.

Filed

2024-12-17

Registered

2025-12-26

Registration Expiry Date

2035-12-26

Registered Owner

HISAMITSU PHARMACEUTICAL CO., INC.
408, Tashirodaikan-machi
Tosu-shi, Saga, 841-0017
JAPAN

Agent

BORDEN LADNER GERVAIS LLP
World Exchange Plaza
100 Queen Street, Suite 1300
Ottawa
ONTARIO K1P1J9

Documents

Index headings

  • HARUROPI

Goods (Nice class & Statement)

5
(1) Medicated transdermal patches, plasters, cataplasms, gels, creams and sprays for the relief of aches and pains of muscles and joints; Anti-inflammatories; analgesics; Gauze for medical purposes; gauze for dressings; Capsules sold empty for pharmaceuticals; Eyepatches for medical purposes; Ear bandages; Menstruation bandages; menstruation tampons, sanitary napkins; Absorbent cotton; Cotton wool for medical purposes; Adhesive plasters, namely, adhesive bandages, surgical adhesives, medical and surgical plasters, bandages for dressings, dressings for wounds, medical dressings, surgical and medical dressings, wadding for wound dressing, wound dressings, dressings for burns, sterile dressings; Breast-nursing pads, breast-nursing padding, breast pads; Cloth diapers, baby diapers, disposable diapers, incontinence diapers; Dietary supplements for general health and well being; dietetic beverages namely, nutritional supplement meal replacement beverages containing vitamins and minerals; nutraceutical beverages for general health and well being; energy drinks for general health and well being; nutritional supplements in liquid form for boosting energy; Antihistamines; decongestants; Pharmaceutical preparations for the treatment of central nervous system diseases; Pharmaceutical preparations for the treatment of Parkinson's disease; Transdermal patches for use in the treatment of central nervous system diseases and disorders; Transdermal patches for use in the treatment of Parkinson's disease.

Action History

Actions
Action Action date Due date Comments
Filed 2024-12-17
Created 2024-12-17
Formalized 2024-12-17
Pre-Assessment Letter Sent 2025-01-02 Goods or Services Not Acceptable
Search Recorded 2025-07-24
Approved 2025-08-01 APPROVED BY PROGRAM EX200M1
Approval Notice Sent 2025-08-01 APPROVED BY PROGRAM EX200M1
Advertised 2025-10-08 Vol.72 Issue 3702
Registration Pending 2025-12-26
Registered 2025-12-26 2035-12-26
Date modified: